3.9 Article

Reliability of T7-based mRNA linear amplification validated by gene expression analysis of human kidney cells using cDNA microarrays

Journal

NEPHRON EXPERIMENTAL NEPHROLOGY
Volume 97, Issue 3, Pages 86-95

Publisher

KARGER
DOI: 10.1159/000078642

Keywords

microarrays; RNA; amplification; gene expression; kidney

Funding

  1. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052841] Funding Source: NIH RePORTER
  2. NIDDK NIH HHS [R01 DK52841] Funding Source: Medline

Ask authors/readers for more resources

Genome wide gene expression analysis by cDNA microarrays is often limited by minute amounts of starting RNA. We therefore tested an optimized linear RNA amplification protocol using the RiboAmp(R) amplification kit in the setting of cDNA microarrays. We isolated mRNA from a human kidney cell line (HK-2; ATCC) and from Universal Human Reference RNA (STR; Stratagene). After performing one and two rounds of linear RNA amplification, respectively, the amplified RNAs were co-hybridized to cDNA microarrays. Linearity and reproducibility of the individual experiments were then assessed by calculating the Pearson correlation. The intra-amplification consistency showed a correlation of 0.968 for the first round, 0.907 for the second round and 0.912 for two successive rounds of amplification. If the first round was compared to unamplified material, r was 0.925. The second round amplification yielded a correlation of 0.897 if compared to unamplified mRNA. Two rounds of amplification starting from 200 pg of mRNA compared to unamplified material resulted in a correlation of 0.868. These results indicate that linear amplification using RiboAmp(R) kit yields amplified RNA with a high degree of linearity and reproducibility. Copyright (C) 2004 S. Karger AG, Basel.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available